Precipio, Inc. (PRPO)
NASDAQ: PRPO · Real-Time Price · USD
23.29
0.00 (0.00%)
Dec 24, 2025, 1:00 PM EST - Market closed
Precipio Revenue
Precipio had revenue of $6.77M in the quarter ending September 30, 2025, with 29.91% growth. This brings the company's revenue in the last twelve months to $22.80M, up 30.95% year-over-year. In the year 2024, Precipio had annual revenue of $18.53M with 21.95% growth.
Revenue (ttm)
$22.80M
Revenue Growth
+30.95%
P/S Ratio
1.61
Revenue / Employee
$380,000
Employees
60
Market Cap
41.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.53M | 3.34M | 21.95% |
| Dec 31, 2023 | 15.20M | 5.79M | 61.46% |
| Dec 31, 2022 | 9.41M | 563.00K | 6.36% |
| Dec 31, 2021 | 8.85M | 2.76M | 45.26% |
| Dec 31, 2020 | 6.09M | 2.97M | 94.82% |
| Dec 31, 2019 | 3.13M | 263.00K | 9.18% |
| Dec 31, 2018 | 2.86M | 1.14M | 66.22% |
| Dec 31, 2017 | 1.72M | - | - |
| Dec 31, 2016 | 1.72M | -206.00K | -10.68% |
| Dec 31, 2015 | 1.93M | 689.00K | 55.56% |
| Dec 31, 2014 | 1.24M | -26.30M | -95.50% |
| Dec 31, 2013 | 27.54M | -3.94M | -12.50% |
| Dec 31, 2012 | 31.48M | -491.00K | -1.54% |
| Dec 31, 2011 | 31.97M | 11.92M | 59.47% |
| Dec 31, 2010 | 20.05M | -1.98M | -8.97% |
| Dec 31, 2009 | 22.02M | -1.97M | -8.21% |
| Dec 31, 2008 | 23.99M | 817.00K | 3.53% |
| Dec 31, 2007 | 23.18M | -239.00K | -1.02% |
| Dec 31, 2006 | 23.42M | -2.41M | -9.34% |
| Dec 31, 2005 | 25.83M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PRPO News
- 20 days ago - Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting - GlobeNewsWire
- 21 days ago - Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact - GlobeNewsWire
- 5 weeks ago - Precipio, Inc. (PRPO) Q3 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
- 5 weeks ago - Precipio Announces its Q3-2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Precipio Announces Q3-2025 Shareholder Update Call - GlobeNewsWire
- 4 months ago - Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Precipio Announces its Q2-2025 Financial Results - GlobeNewsWire
- 5 months ago - Precipio Announces Q2-2025 Shareholder Update Call - GlobeNewsWire